PCMC
PPH icon

Private Capital Management (Colorado)’s VanEck Pharmaceutical ETF PPH Stock Holding History

Private Capital Management (Colorado)’s Portfolio PPH Stock Details PPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-202
Closed -$19.2K – 263
2024
Q3 		$19.2K Buy
+202
New +$19.2K ﹤0.01% 263

Other funds holding PPH

Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
AT
Avalon Trust Santa Fe, New Mexico $1.63B AUM 42.75% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $2.17B AUM 29.66% 1-Year Est. Return
MTWSIF
Mivtachim The Workers Social Insurance Fund Tel Aviv, Israel $759M AUM 84.08% 1-Year Est. Return
MIM
Miller Investment Management West Conshohocken, Pennsylvania $1.09B AUM 18.31% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
AWC
Adamsbrown Wealth Consultants Wichita, Kansas $530M AUM 23.21% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return

Private Capital Management (Colorado)'s PPH Position: Q4 2024 in Review

Private Capital Management (Colorado) sold out of VanEck Pharmaceutical ETF (PPH) in Q4 2024, closing a stake of 202 shares — an estimated $19.2K sold.

Private Capital Management (Colorado) first reported a position in PPH in Q3 2024 and held it in 1 quarter. The position peaked at $19.2K in Q3 2024. 142 funds tracked by Wall St. Rank hold PPH as of Q4 2024.

  • Private Capital Management (Colorado) reported no remaining VanEck Pharmaceutical ETF position as of Q4 2024 after selling out during the quarter.
  • Private Capital Management (Colorado) sold 202 VanEck Pharmaceutical ETF shares in Q4 2024, an estimated $19.2K.
  • Private Capital Management (Colorado) first reported a position in VanEck Pharmaceutical ETF in Q3 2024 and held it in 1 quarter.
  • Private Capital Management (Colorado)'s VanEck Pharmaceutical ETF position peaked at $19.2K in Q3 2024.
  • 142 funds tracked by Wall St. Rank held VanEck Pharmaceutical ETF as of Q4 2024.

Based on Private Capital Management (Colorado)'s 13F filing for Q4 2024, filed 5 Feb 2025.